Showing 2431-2440 of 2812 results for "".
- BTL Announces New EMFACE Facial Devicehttps://modernaesthetics.com/news/btl-announces-new-emface-facial-device/2473183/BTL has announced its latest technology innovation, which the company says is the result of combining many years of institutional knowledge of the simultaneous emission of radio frequency and electromagnetic energies. EMFACE™ utilizes a patented technology of muscle contraction and ski
- Business News: $511M SPAC Merger Deal for Sunevahttps://modernaesthetics.com/news/business-news-511m-spac-merger-deal-for-suneva/2473182/Suneva Medical, Inc. and Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), are joining forces to form a regenerative aesthetics company. Upon completion of the transaction, the combined company's securities are expected to be traded on the NYSE unde
- Does the "No Surprises Act" Apply to Aesthetic Services?https://modernaesthetics.com/news/does-the-no-surprises-act-apply-to-aesthetic-services/2473180/In a chat thread with colleagues on our mutual trade organizations' message board, there was a question about providing Good Faith Estimates (GFE) for aesthetic procedures under the No Surprises Act. I stated that I didn't think GFEs were required for aesthetic procedures, but a represent
- Obagi Rolls Out The Skintrinsiq System Devicehttps://modernaesthetics.com/news/obagi-rolls-out-the-skintrinsiq-system-device/2473178/Obagi is launching the Skintrinsiq device, its first entry into the complementary skincare device market. The Skintrinsiq system extracts impurities then infuses Obagi skincare products via treatment protocols customized for individual skincare needs. "The uni
- Placental Allograft Technology from MiMedx Shown Beneficial for Mohs Repairshttps://modernaesthetics.com/news/placental-allograft-technology-from-mimedx-shown-beneficial-for-mohs-repairs/2473174/MiMedx Group’s Purion® processed dHACM (Epifix®) placental allografts are associated with a statistically significant lower risk for infection, poor scar cosmesis, scar revision, and additional operation at the index site, when compared to traditional methods of incisional repair po
- Registration Open for AACS 2022 Annual Meetinghttps://modernaesthetics.com/news/registration-open-for-aacs-2022-annual-meeting/2473170/Registration is open for the American Academy of Cosmetic Surgery (AACS) 2022 Annual Scientific Meeting. Themed “Immerse in Perfection – Advances in Cosmetic Su
- Galderma to Acquire Alastin Skincarehttps://modernaesthetics.com/news/galderma-to-acquire-alastin-skincare/2473169/Galderma is set to acquire Alastin Skincare®, Inc. The world’s largest independent dermatology company has signed a definitive agreement to acquire the specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. Financial
- Gryphon Investors Signs Deal to Aquire Revision Skincarehttps://modernaesthetics.com/news/gryphon-investors-signs-deal-to-aquire-revision-skincare/2473163/The Middle-market private equity firm Gryphon Investors has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics, with an anticipating closing date this year. Financial terms of the transaction were not disclosed. Revision Goodier's management team
- RoC Skincare: Sunday is National Retinol Dayhttps://modernaesthetics.com/news/roc-skincare-sunday-is-national-retinol-day/2473161/Sunday marks the first-ever National Retinol Day. As people around the country turn their clocks back for daylight savings on November 7, RoC® is bringing attention to the use of retinol to help turn back the clock on fine lines and wrinkles. National Retinol Day has been registered
- FDA Tightens Breast Implant Safety Requirements, Updates Study Resultshttps://modernaesthetics.com/news/fda-tightens-breast-implant-safety-requirements-updates-study-results/2473159/FDA is calling for stronger warnings on breast implants including a boxed warning, which lists such potential risks as infection, rupture, capsular contraction, breast implant illness, and breast implant-associated anaplastic large cell Lymphoma (BIA-ALCL).